Centrifuge Bolsters Liquidity with Symbiotic Integration

Centrifuge has expanded its liquidity options by integrating Symbiotic's Liquid Lane across three major tokenized funds, representing around $1.6 billion in assets under management.

The integration applies to Janus Henderson's JAAA and JTRSY, as well as New York Life Investment Management's HYB. Through Liquid Lane, market makers can access liquidity from vaults via an on-chain request-for-quote marketplace.

This allows them to redeem acquired fund tokens through the issuer or sell them through another RFQ transaction, enabling investors to receive USDC immediately while standard redemption processes continue in parallel.

Centrifuge has seen significant growth driven by institutional products, with Janus Henderson contributing around $1 billion in total value locked through JAAA alone.